PeterGregorCzarneckiMD
Nephrology • Boston, MACritical Care, Hereditary Kidney Disease Genetics
Physician
Dr. Czarnecki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-6383
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Nephrology, 2010 - 2013
Mayo ClinicCritical Care Medicine, 2009 - 2010
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2006 - 2009
Albert Ludwigs University Faculty of MedicineClass of 2005
Certifications & Licensure
MA State Medical License 2010 - 2026
NH State Medical License 2024 - 2024
MN State Medical License 2008 - 2010
Publications & Presentations
PubMed
- 62 citationsB9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis.Katharina Hopp, Christina M. Heyer, Cynthia J. Hommerding, Susan A. Henke, Jamie L. Sundsbak
Human Molecular Genetics. 2011-07-01 - 178 citationsAngiotensin Blockade in Late Autosomal Dominant Polycystic Kidney DiseaseVicente E. Torres, Kaleab Z. Abebe, Arlene B. Chapman, Robert W. Schrier, William E. Braun
The New England Journal of Medicine. 2014-12-10 - 335 citationsBlood Pressure in Early Autosomal Dominant Polycystic Kidney DiseaseRobert W. Schrier, Kaleab Z. Abebe, Ronald D. Perrone, Vicente E. Torres, William E. Braun
The New England Journal of Medicine. 2014-12-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
